RxDoctor Payments Data

Jayme Trahan, MD

Neurological Surgery · Lafayette, LANPI 1700072238

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $59,933 of the $67,531 with a category attached, or 88.7%. The Institute Of Musculoskeletal Science And Education accounts for 94.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $17,937 and has fallen 78.9% since, to $3,784 in 2025.

$67,531in general payments, 2019–2025

Across 103 payments — averaging $655.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$64K
  • Boston Scientific$1K
  • Si-bone, Inc.$881
  • Stryker$550
  • Philadelphia Medical Management Company LLC$307
  • Providence Medical Technology, Inc.$223
  • plus $914 from 11 others
$100,000in ownership & investment interests, 2019–2025

Across 6 payments — averaging $16,667 each. An ownership or investment interest held by the physician or an immediate family member.

  • Philadelphia Medical Management Company LLC$100K

What the payments were for

  • Royalty or licence$59,93389%
  • Consulting fees$1,6002%
  • Travel & lodging$2,0883%
  • Food & beverage$3,0745%
  • Gifts$5301%
  • Ownership interest$3070%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,531 in reported general payments places this provider in the 85th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$185,814
Medicare patients
338
Services billed
1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam14$22

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →